Home Share Prices Stock Picker Financial Diary UK Indices UK Industry Sectors Company Lookup Share Risers Share Fallers Broker Ratings Finance Glossary SMS Services

Share Chat Finance News Blogs Live Prices Shares Bookshop Finance Tools Members

Round table discussion - PRECIOUS METALS

Latest Share Chat

FGP. Sorry that val-
uation of 28800 w..

ACTA. I would like
o know how many bac..

SLE. No beating abo-
ut the bush, I inve..

FGP. if you really
want to keep these(..

BMR. I'm drunk as a
Skunk guys and I d..

BHR. Latest news he-
re in Australia is ..

BMR. http://www.bus-
inessweek.com/news/..

VOD. After many moo-
ns and years turned..

VMP. new next week.
Possibly Wednesday..

BLVN. WHERE IS THE RIG?

Glaxosmithkline Share Price (GSK)

Share Price Information for Glaxosmithkline (GSK)

Share Price: 1,749.50

Bid: 1,747.00

Ask: 1,747.50

Change: 0.00 (0.00%)

Spread: 0.50

Spread as %: 0.03%

Open: 1,743.50

High: 1,750.00

Low: 1,726.50

Yesterday’s Close: 1,749.50

GLAXOSMITHKLINE PLC ORD 25P

Glaxosmithkline is listed in the FTSE 100, FTSE All-Share, FTSE 350
Glaxosmithkline is part of the Pharmaceuticals & Biotechnology sector

Glaxosmithkline has a share of around 5% of the world’s pharmaceutical market, aiming to tackle 3 of the ‘priority’ diseases identified by the World Health Organisation. The company employs around 96,500 people in over 100 countries. In 2010 they delivered 1.4 billion vaccine doses to 179 countries.

Intraday Glaxosmithkline Share Chart

Glaxosmithkline Share Price

Price

1749.50

Bid

1747.00

Ask

1747.50

Change

0.00%

0.00

Volume

4,616,873

Open

1,743.50

High

1,750.00

Low

1,726.50

1,749.50

Currency

GBX

3 Month Glaxosmithkline Share Graph

3 Month Glaxosmithkline Share Price Graph

Currency	Issue Country	Shares in Issue	Market Capitalisation	Market Size
GBX	GB	4,927.85m	£86,212.81m	2,000

52 Week High	1,773.00	52 Week High Date	22-MAY-2013
52 Week Low	1,314.00	52 Week Low Date	19-NOV-2012

# Trades	Vol. Sold	Vol. Bought	PE Ratio	Earnings	Dividend	Yield
5,674	1,565,341	3,031,781	18.832	92.90	74.00	4.23

London South East Users info for Glaxosmithkline

Users who watch GSK also watch: Tesco, Vodafone Grp., Royal Bank Scot, Bp

Users who hold GSK also hold: Bp, Lloyds Grp., Vodafone Grp., Tesco, National Grid

Recent Share Trades for Glaxosmithkline (GSK)

Date

Time

Trade Prc

Volume

Buy/Sell

Bid

Ask

Value

24-May-13

17:04:47

1,738.00

1,600,000

Sell*

1,747.00

1,747.50

27.808M

Trade Type:
Ordinary

24-May-13

16:41:30

1,749.50

25,517

Buy*

1,747.00

1,747.50

446.42k

Trade Type:
Ordinary
Deletion

24-May-13

16:41:28

1,738.0674

17,996

Sell*

1,747.00

1,747.50

312.78k

Trade Type:
Ordinary
Deletion

*Buys and Sells are calculated on the difference between the trade price and the current mid price. As such, they can occasionally be incorrect.

View more Glaxosmithkline trades >>

Trade Date	Action	Notifier	Price	Currency	Amount	Holding
Directors Deals for Glaxosmithkline (GSK)
16-May-13	Transfer To	Sir Andrew P Witty held the position of CEO at GlaxoSmithKline at the time of this trade. Sir Andrew P Witty	1723.58	GBX	670	0
16-May-13	Transfer From	Sir Andrew P Witty held the position of CEO at GlaxoSmithKline at the time of this trade. Sir Andrew P Witty	1723.64	GBX	664	0
16-May-13	Transfer To	Sir Andrew P Witty held the position of CEO at GlaxoSmithKline at the time of this trade. Sir Andrew P Witty	0		1,000	0

View more Glaxosmithkline directors dealings >>

Share Discussion for Glaxosmithkline (GSK)

Date/Time

Author

Subject

Share Price^†

Opinion

Fri 17:37

driftking27

*don't be afraid to look abroad*

1,749.50

Hold

I'd take a look at Novartis ADR, they produce drugs at a cheaper cost especially for developing countries. They have a good dividend policy which has increased for the past 18years, since it first came about. Further it has the best portfolio of medicine and has a great gearing to debt levels. Lastly, Novartis has. $50bn stake in Roche Holdings, which they have been mooted to selling, which would give them massive firepower to make a big acquisition, and also they have the biggest segment in eye care. Plus its trading on a cheaper P/E basis to JNJ, GSK, PFE, MRK, RHHBY, TEVA.

Fri 10:07

chris47

trader

1,738.00

Buy

judging by your name trader take your profit and keep away from aim stocks

Fri 09:56

chris47

trader

1,737.50

Buy

if you sell you will be pleased to see them fall 2 quid if you hold and they fall you will be kicking yourself if they go up another 2 quid how will you feel ???

Fri 09:49

chris47

usa

1,741.50

Buy

http://www.barchart.com/opinions/stocks/GSK the americans are driving this stock higher chasing yield and 4 .5 pc looks good to them and they like stock buybacks

Fri 09:44

chris47

trader

1,741.00

Buy

i bought in gsk 7 years ago. seen a low of 10 quid and a high of 17 70 plus about 425 in dividends. this last 4 months have been good. lots of guys sold at 15 quid and thought they called the high i bet they regret selling now if you are happy with the profit then take it but remember you have to find another home for the money you invested

Thu 17:09

TraderTrader

How long to hold

1,742.00

No Opinion

I have some Glaxo up 16% march, how long to hold?

^†Share prices shown are taken at time of message posting.

Thread View
View more share chat for Glaxosmithkline (GSK) >>

Please Login or Register to post messages

Request your Free brochures on share dealing, spread betting and CFDs

Website: GLAXOSMITHKLINE PLC ORD 25P
Website Description: GlaxoSmithKline - Redirect

Datafeed and UK data supplied by NETbuilder and Interactive Data. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk!
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.